Lv75
4400 积分 2021-03-01 加入
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
49分钟前
待确认
Presence of hepatitis B virus markers in umbilical cord blood: Exposure to or infection with the virus?
6天前
已完结
Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss
6天前
已完结
HOW DO PATIENTS EXPERIENCE A KIDNEY BIOPSY?
14天前
已完结
The pathogenesis of IgA nephropathy and implications for treatment
18天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
18天前
已完结
Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia
1个月前
已完结
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
3个月前
已完结
Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis
3个月前
已完结
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
